​

uniQure (QURE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

QURE Stock Forecast

uniQure (QURE) stock forecast, based on 35 Wall Street analysts, predicts a 12-month average price target of $41.80, with a high of $95.00 and a low of $11.00. This represents a 146.75% increase from the last price of $16.94.

- $19 $38 $57 $76 $95 High: $95 Avg: $41.8 Low: $11 Last Closed Price: $16.94

QURE Stock Rating

uniQure stock's rating consensus is Buy, based on 35 Wall Street analysts. The breakdown includes 1 Strong Buy (2.86%), 29 Buy (82.86%), 5 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 35 5 29 1 Strong Sell Sell Hold Buy Strong Buy

QURE Price Target Upside V Benchmarks

TypeNameUpside
StockuniQure146.75%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts5618
Avg Price Target$30.20$30.33$49.33
Last Closing Price$16.94$16.94$16.94
Upside/Downside78.28%79.04%191.20%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26195--15
Feb, 26193--13
Jan, 26192--12
Dec, 25192--12
Nov, 25291--12
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 09, 2026Daniil GataulinChardan Capital$31.00$17.9972.32%83.00%
Mar 09, 2026Yanan ZhuWells Fargo$60.00$17.69239.17%254.19%
Mar 02, 2026Joseph SchwartzLeerink Partners$35.00$10.50233.33%106.61%
Mar 02, 2026Luca IssiRBC Capital$11.00$10.257.32%-35.06%
Mar 02, 2026Paul MatteisStifel Nicolaus$14.00$10.3035.92%-17.36%
Jan 27, 2026Barclays$31.00$24.3727.21%83.00%
Dec 11, 2025Stifel Nicolaus$40.00$20.1298.81%136.13%
Dec 08, 2025Uy EarMizuho Securities$33.00$21.7751.58%94.81%
Nov 04, 2025Patrick TrucchioH.C. Wainwright$70.00$34.29104.14%313.22%
Nov 04, 2025Goldman Sachs$38.00$34.2910.82%124.32%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 09, 2026Wells FargoOverweightOverweightupgrade
Mar 03, 2026BernsteinMarket Performdowngrade
Mar 02, 2026Leerink PartnersOutperformOutperformhold
Mar 02, 2026RBC CapitalOutperformSector Performdowngrade
Mar 02, 2026Cantor FitzgeraldOverweightNeutralupgrade
Feb 26, 2026RBC CapitalOutperformOutperformhold
Feb 23, 2026Wolfe ResearchPeer Performinitialise
Jan 14, 2026Cantor FitzgeraldOverweightOverweighthold
Nov 11, 2025William BlairMarket PerformMarket Performhold
Nov 04, 2025RBC CapitalOutperformOutperformhold

Financial Forecast

EPS Forecast

$-15 $-8 $-1 $6 $13 $20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.17$-2.71$-6.47$-4.92$-3.46---
Avg Forecast$6.17$-3.75$-6.31$-4.08$-3.38$-2.65$0.24$1.59
High Forecast$19.18$-0.76$-5.52$-2.60$-2.04$-1.18$0.94$4.29
Low Forecast$0.81$-12.82$-6.79$-4.81$-4.08$-3.47$-1.77$0.02
Surprise %16.21%-27.73%2.54%20.59%2.37%---

Revenue Forecast

$0 $300M $600M $900M $1B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$524.00M$106.48M$15.84M$27.12M$16.10M---
Avg Forecast$475.82M$30.57M$20.88M$41.03M$35.04M$115.19M$224.16M$426.50M
High Forecast$1.25B$87.54M$24.70M$87.71M$80.89M$265.96M$230.88M$984.69M
Low Forecast$157.60M$11.85M$17.22M$16.50M$8.45M$27.78M$217.44M$102.84M
Surprise %10.13%248.31%-24.11%-33.91%-54.05%---

Net Income Forecast

$-400M $-240M $-80M $80M $240M $400M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$329.59M$-126.79M$-308.48M$-239.56M$-198.97M---
Avg Forecast$278.41M$-158.89M$-308.48M$-176.70M$-157.36M$-121.56M$-54.56M$75.77M
High Forecast$386.84M$-120.98M$-234.86M$-124.03M$-97.07M$-56.14M$44.92M$204.69M
Low Forecast$169.98M$-196.81M$-382.09M$-229.37M$-194.66M$-165.31M$-84.60M$1.02M
Surprise %18.38%-20.20%-35.57%26.45%---

QURE Forecast FAQ

Is uniQure stock a buy?

uniQure stock has a consensus rating of Buy, based on 35 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 29 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that uniQure is a favorable investment for most analysts.

What is uniQure's price target?

uniQure's price target, set by 35 Wall Street analysts, averages $41.8 over the next 12 months. The price target range spans from $11 at the low end to $95 at the high end, suggesting a potential 146.75% change from the previous closing price of $16.94.

How does uniQure stock forecast compare to its benchmarks?

uniQure's stock forecast shows a 146.75% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for uniQure over the past three months?

  • March 2026: 6.67% Strong Buy, 60.00% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 7.69% Strong Buy, 69.23% Buy, 23.08% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 8.33% Strong Buy, 75.00% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.

What is uniQure’s EPS forecast?

uniQure's average annual EPS forecast for its fiscal year ending in December 2026 is $-2.65, marking a -23.41% decrease from the reported $-3.46 in 2025. Estimates for the following years are $0.24 in 2027, and $1.59 in 2028.

What is uniQure’s revenue forecast?

uniQure's average annual revenue forecast for its fiscal year ending in December 2026 is $115.19M, reflecting a 615.57% increase from the reported $16.1M in 2025. The forecast for 2027 is $224.16M, and $426.5M for 2028.

What is uniQure’s net income forecast?

uniQure's net income forecast for the fiscal year ending in December 2026 stands at $-122M, representing a -38.90% decrease from the reported $-199M in 2025. Projections indicate $-54.563M in 2027, and $75.77M in 2028.